| Literature DB >> 33324584 |
Yanchen Wu1, Baiyan Gong1, Xiaohua Liu1, Yanyan Jiang2, Jianping Cao2, Lan Yao1, He Li1, Aiqin Liu1, Yujuan Shen2.
Abstract
Cryptosporidium and Giardia are two important zoonotic intestinal protozoa responsible for diarrheal diseases in humans and animals worldwide. Feces from infected hosts, water and food contaminated by Cryptosporidium oocysts and Giardia cysts as well as predictors such as poverty have been involved in their transmission. Myanmar is one of the world's most impoverished countries. To date, there are few epidemiological studies of Cryptosporidium and Giardia in humans. To understand the prevalence and genetic characterization of Cryptosporidium spp. and Giardia duodenalis in humans in Myanmar, a molecular epidemiological investigation of the two protozoa was conducted in four villages of Shan State. 172 fecal specimens were collected from Wa people (one each) and identified for the presence of Cryptosporidium spp. and G. duodenalis by sequence analysis of their respective small subunit ribosomal RNA genes. 1.74% of investigated people were infected with Cryptosporidium spp.-C. andersoni (n = 2) and C. viatorum (n = 1) while 11.05% infected with G. duodenalis-assemblages A (n = 6) and B (n = 13). By sequence analysis of 60-kDa glycoprotein gene, the C. viatorum isolate belonged to a novel subtype XVcA2G1c. DNA preparations positive for G. duodenalis were further subtyped. Five of them were amplified and sequenced successfully: different assemblage B sequences (n = 2) at the triosephosphate isomerase (tpi) locus; sub-assemblage AII sequence (n = 1) and identical assemblage B sequences (n = 2) at the β-giardin (bg) locus. This is the first molecular epidemiological study of Cryptosporidium spp. and G. duodenalis in humans in Myanmar at both genotype and subtype levels. Due to unclear transmission patterns and dynamics of Cryptosporidium spp. and G. duodenalis, future research effort should focus on molecular epidemiological investigations of the two parasites in humans and animals living in close contact in the investigated areas, even in whole Myanmar. These data will aid in making efficient control strategies to intervene with and prevent occurrence of both diseases.Entities:
Keywords: Cryptosporidium; Giardia; genotyping; humans; subtyping
Year: 2020 PMID: 33324584 PMCID: PMC7724083 DOI: 10.3389/fcimb.2020.614053
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1A map showing the sampling site of human fecal specimens in this study.
Prevalence and genetic characterization of Cryptosporidium spp. and G. duodenalis in humans.
| Age group (years) | Examined no. |
|
| |||||
|---|---|---|---|---|---|---|---|---|
| No. of positive (%) | Species | Subtype | No. of positive (%) | Assemblage | Sub-assemblage | |||
| SSU rRNA (n) | Gp60 (n) | SSU rRNA (n) | tpi (n) | bg (n) | ||||
| Children (<13) | 97 | 1 (1.03) |
| XVcA2G1c (1) | 12 (12.37) | B (9); A (3) | B-I (1) | B (2); AII (1) |
| Teenagers (13–17) | 41 | 0 | − | − | 7 (17.07) | B (4); A (3) | B-II (1) | − |
| Adults (≥18) | 34 | 2 (5.88) |
| − | 0 | − | − | − |
| Total | 172 | 3 (1.74) |
| XVcA2G1c (1) | 19 (11.05) | B (13); A(6) | B-I (1); B-II (1) | B (2); AII (1) |
The bars denote negative results at the locus.
Prevalence of Cryptosporidium spp. and G. duodenalis by age and symptom.
| Group | Examined no. |
|
| |||||
|---|---|---|---|---|---|---|---|---|
| Positive no. (%) | ORa (95% CIb) |
| Positive no. (%) | ORa (95% CIb) |
| |||
| Age | Children | 97 | 1 (1.03) | Ref | 12 (12.37) | Ref | ||
| Teenagers | 41 | 0 | 0.99 (0.97, 1.01) | −/1.00c | 7 (17.07) | 0.69 (0.25, 1.89) | 0.54/0.46 | |
| Adults | 34 | 2 (5.88) | 0.17 (0.02, 1.90) | 0.92/0.34 | 0 | 0.88 (0.81, 0.94) | − | |
| Symptom | Diarrhea | 42 | 0 | 1.02 (1.00, 1.05) | −/1.00c | 4 (9.52) | 0.81 (0.25, 2.58) | 0.01/0.94 |
| Non-diarrhea | 130 | 3 (2.31) | 15 (11.54) | |||||
aOR Odds ratio. bCI Confidence interval. cFisher’s exact test. dBold type for values indicates statistical significance.
Relationships between Cryptosporidium spp. or G. duodenalis infection and diarrhea in each age group.
| Group | Symptom | Examined no. |
|
| ||||
|---|---|---|---|---|---|---|---|---|
| Positive no. (%) | ORa (95% CIb) |
| Positive no. (%) | ORa (95% CIb) |
| |||
| Children | Diarrhea | 26 | 0 | 1.01 (0.99, 1.04) | −/1.00c | 2 (7.69) | 0.51 (0.10, 2.49) | 0.25/0.62 |
| Non-diarrhea | 71 | 1 (1.41) | 10 (14.08) | |||||
| Teenagers | Diarrhea | 14 | 0 | − | − | 2 (14.29) | 0.73 (0.12, 4.37) | −/1.00 |
| Non-diarrhea | 27 | 0 | 5 (18.52) | |||||
| Adults | Diarrhea | 2 | 0 | 1.07 (0.96, 1.17) | −/1.00c | 0 | − | − |
| Non-diarrhea | 32 | 2 (6.25) | 0 | |||||
aOR Odds ratio, bCI Confidence interval, cFisher’s exact test.
Figure 2Phylogenetic relationship of gp60 subtypes of Cryptosporidium viatorum. The relationships among C. viatorum subtypes identified in the present study and those deposited in the GenBank were inferred by a neighbor-joining analysis of gp60 gene sequences based on genetic distance by the Kimura 2-parameter model. The numbers on the branches are percent bootstrapping values from 1000 replicates. Each sequence is identified by its accession number and subtype designation. The triangle filled in black indicates the subtype identified in this study.
Pairwise differences (percentage) among gp60 subtypes of C. viatorum for nucleotide (below the diagonal) and amino acid sequences (above the diagonal).
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | – | 0 | 0 | 0.79 | 0.79 | 2.38 | 0.40 | 0.79 | 3.16 | 28.40 | 4.40 | 5.20 | 5.20 | 4.40 | 33.20 | 1 | XVaA3a |
| 2 | 0.25 | – | 0 | 0.79 | 0.79 | 2.38 | 0.40 | 0.79 | 3.16 | 28.40 | 4.40 | 5.20 | 5.20 | 4.40 | 33.20 | 2 | XVaA3b |
| 3 | 0.12 | 0.12 | – | 0.79 | 0.79 | 2.38 | 0.40 | 0.79 | 3.16 | 28.40 | 4.40 | 5.20 | 5.20 | 4.40 | 33.20 | 3 | XVaA3c |
| 4 | 0.50 | 0.50 | 0.37 | – | 0.79 | 2.39 | 0.40 | 0.79 | 3.17 | 28.92 | 4.42 | 5.22 | 5.22 | 4.42 | 34.14 | 4 | XVaA3d |
| 5 | 1.00 | 1.00 | 0.87 | 0.75 | – | 1.58 | 0.39 | 0 | 2.75 | 28.97 | 3.97 | 4.76 | 4.76 | 3.97 | 33.73 | 5 | XVaA3e |
| 6 | 1.50 | 1.50 | 1.38 | 1.25 | 0.49 | – | 1.98 | 1.58 | 2.77 | 29.60 | 4.00 | 4.80 | 4.80 | 4.00 | 33.60 | 6 | XVaA3f |
| 7 | 0.49 | 0.49 | 0.37 | 0.25 | 0.62 | 1.12 | – | 0.39 | 2.76 | 29.08 | 3.98 | 4.78 | 4.78 | 3.98 | 33.86 | 7 | XVaA3g |
| 8 | 0.62 | 0.62 | 0.49 | 0.37 | 0.49 | 0.99 | 0.12 | – | 2.36 | 29.08 | 3.59 | 4.38 | 4.38 | 3.59 | 33.86 | 8 | XVaA3h |
| 9 | 1.62 | 1.62 | 1.50 | 1.63 | 1.24 | 1.24 | 1.49 | 1.37 | – | 28.85 | 3.95 | 5.53 | 5.53 | 3.95 | 32.81 | 9 | XVaA6 |
| 10 | 16.81 | 16.97 | 16.97 | 17.04 | 17.54 | 17.78 | 17.53 | 17.69 | 17.96 | – | 30.80 | 31.20 | 31.20 | 30.80 | 23.83 | 10 | XVbA2G1 |
| 11 | 2.53 | 2.53 | 2.40 | 2.28 | 2.13 | 2.14 | 2.39 | 2.26 | 2.25 | 17.62 | – | 1.57 | 1.57 | 0.39 | 35.60 | 11 | XVcA2G1 |
| 12 | 3.18 | 3.18 | 3.05 | 2.93 | 2.52 | 2.53 | 2.78 | 2.65 | 2.90 | 17.93 | 0.86 | – | 0 | 1.96 | 36.00 | 12 | XVcA2G1a |
| 13 | 3.31 | 3.31 | 3.18 | 3.06 | 2.65 | 2.66 | 2.91 | 2.78 | 3.03 | 18.10 | 0.99 | 0.12 | – | 1.96 | 36.00 | 13 | XVcA2G1b |
| 14 | 2.66 | 2.66 | 2.53 | 2.41 | 2.13 | 2.14 | 2.39 | 2.26 | 2.25 | 17.79 | 0.12 | 0.86 | 0.99 | – | 35.60 | 14 |
|
| 15 | 19.55 | 19.57 | 19.39 | 19.83 | 20.69 | 20.60 | 20.32 | 20.49 | 19.71 | 12.61 | 21.29 | 21.97 | 22.16 | 21.47 | – | 15 | XVdA3 |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 |
The bolded subtype was obtained in the present study.
Geographical distribution of C. viatorum subtypes identified in humans and their travel history.
| Host | Country/Travel history | Case number | Subtype (n) | Reference | |
|---|---|---|---|---|---|
| Diarrhea | Non-diarrhea | ||||
| Human | Australia/NA | 1 | XVaA3g (1) |
| |
| China/NA | 1 | XVaA3h (1) |
| ||
| Colombia/NA | 1 | − |
| ||
| Ethiopia/NA | 8 | 2; 2 | XVaA3d (9) |
| |
| India/NA | 2 | − |
| ||
| Myanmar/NA | 1 |
| This study | ||
| Nigeria/NA | 2 | − |
| ||
| Sweden/Kenya; Guatemala | 3 | XVaA3d (1); XVaA3c (1); XVaA3b (1) |
| ||
| UK/India; Barbados; Pakistan; Nepal; Bangladesh | 13 | 1 | XVaA3a (9), XVaA3f (2); XVaA3d (2); XVaA3e (1) |
| |
| Total | 28 | 5; 4 | XVaA3a (9),XVaA3b (1); XVaA3c (1);XVaA3d (12); XVaA3f (2); XVaA3e (1); XVaA3h (1); XVaA3g (1); XVcA2G1c (1) | ||
NA, not available.
The bars denote negative results at the locus.
The bolded subtype was obtained in the present study.
Cases having no information on clinical symptoms.
Geographical distribution of C. viatorum subtypes in animals.
| Host | Country | Case number | Subtype (n) | Reference | |||
|---|---|---|---|---|---|---|---|
| XVa | XVb | XVc | XVd | ||||
| Australian swamp rats | Australia | 3 | XVbA2G1b (3) |
| |||
| Edward’s long-tailed rats | China | 11 | XVcA2G1a (4); XVcA2G1b (1) | XVdA3 (1) |
| ||
| China | 4 | XVaA6 (2) |
| ||||
| Bower’s white-toothed rats | China | 21 | XVaA3g (7); XVaA3h (7) | XVcA2G1 (1) |
| ||
| Total | 39 | XVaA6 (2); XVaA3g (7); XVaA3h (7) | XVbA2G1b (3) | XVcA2G1a (4); XVcA2G1b (1); XVcA2G1 (1) | XVdA3 (1) | ||